Literature DB >> 28317096

The use of enrichment to reduce statistically indeterminate or negative trials in critical care.

M Shankar-Hari1,2, G D Rubenfeld3.   

Abstract

Keywords:  ARDS; critical care; enrichment; heterogeneity; sepsis

Mesh：

Year:  2017        PMID： 28317096     DOI： 10.1111/anae.13870

Source DB:  PubMed          Journal:  Anaesthesia        ISSN： 0003-2409            Impact factor:   6.955


× No keyword cloud information.
  11 in total

1.  Acute respiratory distress syndrome (ARDS) phenotyping.

Authors:  M Shankar-Hari; E Fan; N D Ferguson
Journal:  Intensive Care Med       Date:  2018-12-05       Impact factor: 17.440

2.  Initiation of renal replacement therapy in patients with sepsis: more to it than meets the eye.

Authors:  Fabrice Uhel; Hessel Peters-Sengers; Tom van der Poll
Journal:  Ann Transl Med       Date:  2018-12

Review 3.  The intensive care medicine research agenda on septic shock.

Authors:  Anders Perner; Anthony C Gordon; Derek C Angus; Francois Lamontagne; Flavia Machado; James A Russell; Jean-Francois Timsit; John C Marshall; John Myburgh; Manu Shankar-Hari; Mervyn Singer
Journal:  Intensive Care Med       Date:  2017-05-12       Impact factor: 17.440

Review 4.  Immunoglobulins and sepsis.

Authors:  Manu Shankar-Hari; Martin Bruun Madsen; Alexis F Turgeon
Journal:  Intensive Care Med       Date:  2018-01-18       Impact factor: 17.440

5.  Host-Response Subphenotypes Offer Prognostic Enrichment in Patients With or at Risk for Acute Respiratory Distress Syndrome.

Authors:  Georgios D Kitsios; Libing Yang; Dimitris V Manatakis; Mehdi Nouraie; John Evankovich; William Bain; Daniel G Dunlap; Faraaz Shah; Ian J Barbash; Sarah F Rapport; Yingze Zhang; Rebecca S DeSensi; Nathaniel M Weathington; Bill B Chen; Prabir Ray; Rama K Mallampalli; Panayiotis V Benos; Janet S Lee; Alison Morris; Bryan J McVerry
Journal:  Crit Care Med       Date:  2019-12       Impact factor: 7.598

6.  Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort study.

Authors:  Manu Shankar-Hari; Deepankar Datta; Julie Wilson; Valentina Assi; Jacqueline Stephen; Christopher J Weir; Jillian Rennie; Jean Antonelli; Anthony Bateman; Jennifer M Felton; Noel Warner; Kevin Judge; Jim Keenan; Alice Wang; Tony Burpee; Alun K Brown; Sion M Lewis; Tracey Mare; Alistair I Roy; John Wright; Gillian Hulme; Ian Dimmick; Alasdair Gray; Adriano G Rossi; A John Simpson; Andrew Conway Morris; Timothy S Walsh
Journal:  Intensive Care Med       Date:  2018-10-05       Impact factor: 17.440

7.  Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study.

Authors:  Julie K Wilson; Yuan Zhao; Mervyn Singer; Jo Spencer; Manu Shankar-Hari
Journal:  Crit Care       Date:  2018-04-17       Impact factor: 9.097

8.  Commentary: Arguing for Adaptive Clinical Trials in Sepsis.

Authors:  Miriam Kesselmeier; André Scherag
Journal:  Front Immunol       Date:  2018-10-30       Impact factor: 7.561

9.  How could we enhance translation of sepsis immunology to inform immunomodulation trials in sepsis?

Authors:  M Shankar-Hari
Journal:  Crit Care       Date:  2017-05-26       Impact factor: 9.097

10.  Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.

Authors:  Shalini Santhakumaran; Anthony Gordon; A Toby Prevost; Cecilia O'Kane; Daniel F McAuley; Manu Shankar-Hari
Journal:  Crit Care       Date:  2019-05-03       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.